Money Talks: Nvidia's $50M Dive into AI Drug Discovery at Recursion
About this episode
In this episode, we dissect Nvidia's financial commitment of $50 million to power Recursion's AI-based drug discovery initiatives, shedding light on the potential game-changing developments in the intersection of artificial intelligence and healthcare.
-
Invest in AI Box: https://Republic.com/ai-box
-
Get on the AI Box Waitlist: https://AIBox.ai/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Get every episode summarized
Each time Today, Explained AI publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Today, Explained AI
GPT-6 Update: ChatGPT and Grok Crashes Explained
Today, Explained AI
OpenAI Astra: Big Changes for AI Development
Today, Explained AI
Understanding ChatGPT and Claude in Work
Today, Explained AI
Key Developments in AI and Tech
Today, Explained AI